Search Results - Gómez de Travecedo Y Calvo, MT

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    4CPS-119 Pneumonology-pharmacy collaboration in the pharmacotherapeutic optimisation of monoclonal antibodies in patients with severe uncontrolled asthma

    4CPS-119 Pneumonology-pharmacy collaboration in the pharmacotherapeutic optimisation of monoclonal antibodies in patients with severe uncontrolled asthma by Alcala Soto, A, Pérez Grimaldi, F, Soto Campos, JG, Cuadros Martínez, CM, Gómez de Travecedo Y Calvo, MT, Sierra Sánchez, JF

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    5PSQ-092 Profile and complexity level of clinical trials in the pharmacy service

    5PSQ-092 Profile and complexity level of clinical trials in the pharmacy service by Gazquez Perez, R, Alcala Soto, A, Puivecino Moreno, C, Pichardo Jiménez, L, Varas Pérez, A, Sánchez-Matamoros Piazza, V, Sierra Sánchez, JF, Gómez Germá, P, Mora Herrera, C, Gómez de Travecedo y Calvo, MT

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    5PSQ-110 Correlation between polymedication and prescrption drugs quality

    5PSQ-110 Correlation between polymedication and prescrption drugs quality by Sierra-Sanchez, JF, Vega, T Gonzalez-Carrascosa, Gavira-Moreno, R, Vazquez-Vela, V, Calvo, MT Gómez de Travecedo y

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    5PSQ-049 Effectiveness and renal safety of taf/ftc/evg/cobi in real clinical practice

    5PSQ-049 Effectiveness and renal safety of taf/ftc/evg/cobi in real clinical practice by Soto, A Alcalá, Pichardo, L Jiménez, Germá, P Gómez, Pérez, A Varas, Moreno, C Puivecino, Ariza, I Marín, Calvo, MT Gómez de Travecedo y

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    5PSQ-074 Activity of enzalutamide after abiraterone in castration-resistant prostate cancer

    5PSQ-074 Activity of enzalutamide after abiraterone in castration-resistant prostate cancer by Soto, A Alcalá, Moreno, R Gavira, Sánchez, JF Sierra, Pérez, A Varas, Pichardo, L Jiménez, Moreno, C Puivecino, Calvo, MT Gómez de Travecedo y

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    DI-037 Risk of hypertension in patients treated with mirabegron. Strategy for prioritisation of a drug safety warning

    DI-037 Risk of hypertension in patients treated with mirabegron. Strategy for prioritisation of a drug safety warning by Pérez, R Gázquez, Pichardo, L Jiménez, Sánchez, JF Sierra, Bonilla, A García, Corrales, O Rojas, Soto, A Alcalá, de Travecedo y Calvo, MT Gómez, Germá, P Gómez, Moreno, R Gavira, Vicente, MA Almendral

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    5PSQ-045 Safety profile of sunitinib in real clinical practice

    5PSQ-045 Safety profile of sunitinib in real clinical practice by Alcala Soto, A, Puivecino Moreno, C, Gazquez Perez, R, Varas Perez, A, Sanchez-Matamoros Piazza, V, Jimenez Pichardo, L, Vazquez Vela, V, Sierra Sanchez, JF, Gavira Moreno, R, Gomez de Travecedo Y Calvo, MT

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    CP-233 Reasons for switching antiretroviral therapy in NAÏve HIV positive patients

    CP-233 Reasons for switching antiretroviral therapy in NAÏve HIV positive patients by Gil, E Atienza, Germá, P Gómez, Herrera, C Mora, de Travecedo y Calvo, MT Góme, Moreno, R Gavira, Sánchez, JF Sierra, Pichardo, L Jiménez, Soto, A Alcalá, Moreno, C Puivecino, Vicente, MA Almendral

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: